NCT06863259 2026-02-18Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALLChildren's Hospital Medical Center, CincinnatiPhase 1 Recruiting28 enrolled
NCT05016947 2026-01-29Venetoclax Plus Inotuzumab for B-ALLDana-Farber Cancer InstitutePhase 1 Active not recruiting23 enrolled